Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

FED × Melanoma × Clear all

Phase

Status

Sponsor Class

OTHER 1481 INDUSTRY 975 NIH 258 NETWORK 56 OTHER_GOV 29 UNKNOWN 4 INDIV 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 48 Colorectal Neoplasms 37 Neoplasms 31 Lung Neoplasms 20 Breast Neoplasms 14 Colonic Neoplasms 13 Colonic Polyps 11 Rare Diseases 8 Carcinoma, Non-Small-Cell Lung 8 Carcinoma, Hepatocellular 7 Ovarian Neoplasms 6 Rectal Neoplasms 5 Motor Activity 5 Heart Failure 5 Adenoma 5 Urinary Bladder Neoplasms 4 Pulmonary Disease, Chronic Obstructive 4 Neoplasm Metastasis 4 Mental Disorders 4 Lymphoma 4 Lung Diseases 4 Liver Neoplasms 4 Leukemia 4 Head and Neck Neoplasms 4 Fibrosis 4 Esophageal Neoplasms 4 Barrett Esophagus 4 Urinary Incontinence 3 Patient Compliance 3 Pain 3

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00029900 2015-03-25

ADI-PEG in Patients With Metastatic Melanoma

FDA Office of Orphan Products Development

Phase 1 Completed

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡